CSL GOES "SHAKE IT. BAKE IT. BOOTY QUAKE IT. ROLL IT AROUND".CSL Ltd is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions.
CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications.
The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994.
The main annual technical chart says, in the year 2025 CSL stock goes the worst year since 2002 (where it halved in price, and even more) after unprecedented 400x run over the past 30-year time span, while its RSI(14) rocketed above '90' for a straight seven years in a row.
We watch close its further potential bearish action, with tap & hold '70-80' area, that is near CSL 30-year average.
--
Best wishes,
@PandorraResearch Team
CSL
ASX Weekly Market Wrap: XJO, LYC, CBA, BHP, CSL, ANZ, WDS, EOSIn this week’s market analysis of the Australian market , we break down key price movements and trends across the #ASX, with a close look at the XJO and standout stocks like Lynas Rare Earths (#LYC), Commonwealth Bank (#CBA), BHP Group (#BHP), CSL Limited (#CSL), ANZ Bank (#ANZ), Woodside (#WDS), and EOS (#EOS).
We explore current momentum, trend direction, and price action indicators to help you understand Aussie market developments. Whether you're paper trading or keeping track of market trends, this is your essential guide for the week ahead.
*Apologies for the incorrectly dated chart of 2027! We are not there yet! 😅
Time to enter ASX:CSL ⁉️Last week, CSL management received positive feedback and the stock is currently in a base. While there is no confirmation of a new trend, the risk-reward ratio is favorable to add a small amount and let the market guide for further additions. I will only add up to 50% of my position in the low base, so if the stock fails to reach its all-time high, I will still have some gains to take away. The stock symbol is $ASX:CSL.
Disclosure: I am investing in my super account for the first trance I cannot provide any recommendations to buy or sell. It is essential for you to conduct your own research.
Carlisle trading above channelCarlisle Cos Inc. (CSL) presently trading above significant channel resistance. If a weekly settlement above this channel resistance occurs, this would place (CSL) in a buy signal where gains of 15% would be expected within 2-3 months, and 20-25% within 5-8 months. Inversely, if (CSL) does not manage to close above the channel resistance, the market may turn bearish with anticipated losses of about 20% over the next 2-3 months.
CSL.ASX_Bullish Breakout Trade_LongENTRY: 299.20
SL: 285.64
TP: 317.82
- ADX<25. Would like to be higher.
- Daily RS +ve
- Daily FFI +ve
- Weekly RS +ve
- Weekly FFI +ve
- Moving averages are aligned.
- Breakout of consolidation area on 6 Jul 2022 before going into another consolidation range.
- Recovered well on 17 Aug 2022 after earnings indicating possible buyers still in play.
- Entry today based on breakout and rebound off 10EMA and 20EMA with volume. Would like the rebound to be >3%.
CSL for a breakout & grind higher on improving fundamentalsCSL is seeing improved plasma collection as places like the US start to return to normal. Additionally the Vifor acquisition should complete in the next few months with the potential for the stock to re-rate higher. The stock has formed an ascending triangle formation with resistance being tested on multiple occasions at the 273/274 level at which a major stock placement to fund the Vifor acquisition was recently conducted. A breakout at 274 was observed with the stock pulling back to retest that level as support. With improving fundamentals and a bullish chart formation, I think this stock is good for a trade. Targetting 297 to the upside as measured by triangle width and aligning with level from which the stock fell when the recent placement was announced. Placing stops just below the ascending trendline.
CSL - Are the Bulls Entering at Support@As we can see that the Support Zone of $268.00 - $274.00 has been strong because it got bounced off in the end of July 2020, and price made a high of $320.00 then. Now that CSL was plunging, the same support has held very well and we can see the downtrend line violated, with a Bullish Candle closing above it, with High Volume.
MACD has also crossed and RSI has come out of the Oversold region, indicating that the Bullls have taken control and want to take it higher. My targets are as follows:
1. TP1 is $287.00 - $290.00 region (Resistance 1) (4% - 5% potential)
2. TP2 is $298.00 - $300.00 region (Resistance 2) (8% - 9% potential)
Please note these are my own notes, by no means trading advice. Please do your own research before entering into any trade.
CSL goes to next level at 356Based on the chart, we can see a breakout, retest point at around 307 with a huge volume.
CSL is sideway, if it break the resistance at 320, it'll go to the previous ATH then 356 based on Elliott Impulse Wave.
I think investors will taking profit, because appearing a doji candle on the top in 31 Aug and 23 Sep. Caution that!!!
Share with me about your thought.
Biotech - CSLModel has given entry signals for CSL Limited:
- CSL Limited is a global specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions.
- We are very excited about opportunities in the biotech sector, as we believe the fight against COVID is going to move to the next phase in the nearest future.
- Technically in a Wyckoff accumulation structure with a spring, possibly testing the channel top.
GLHF,
DPT
Disclaimer:
We absolutely do not provide financial advice in any shape or form. We do not recommend investing based on our opinions and strongly cautions that securities trading and investment involves high risk and that you can lose a lot of money. Loss of principal is possible. We do not recommend risking money you cannot afford to lose. We do not guarantee future performance nor accuracy in historical analyses. We are not registered investment advisors. Our ideas, opinions and statements are not a substitute for professional investment advice. We provide ideas containing impersonal market observations and our opinions. Our speculations may be used in preparation to form your own ideas.
CSL - A Potential buy Plan?CSL could be bottoming, as it appears so on the Weekly chart after it bounced off support with High Volume. Could it be a double bottom? Maybe, only time will tell. At this point, it seems that it may have bottomed medium term and may move higher. My trade plan is as follows:
TP1 - $270.00 (potential gain 6%)
TP2 - $288.00 (potential gain 13%)
Stoploss - $237.00
Please note these are my own notes, by no means trading advice. Please do your own research before entering into any trade.






















